Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey

Author： Scheubel Emmanuel   Adamy Laurent   Hoffart Valerie   Michel Cardot Jean  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.36, Iss.11, 2010-11, pp. : 1320-1329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of a Suitable Dissolution Method for the Combined Tablet Formulation of Atorvastatin and Ezetimibe by RP-LC Method

By  

Current Drug Delivery, Vol. 13, Iss. 3, 2016-05 ,pp. : 424-432

Bentham Science Publishers

Access to resources Recommend Favorite

An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC

By  

Current Drug Delivery, Vol. 15, Iss. 1, 2018-01 ,pp. : 87-96

Bentham Science Publishers

Access to resources Recommend Favorite

From Drug Delivery Systems to Drug Release, Dissolution, IVIVC, BCS, BDDCS, Bioequivalence and Biowaivers

By Karalis Vangelis   Magklara Eleni   Shah Vinod   Macheras Panos  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 2018-2029

Springer Publishing Company

Access to resources Recommend Favorite

Compritol®888 ATO a Lipid Excipient for Sustained Release of Highly Water Soluble Active: Formulation, Scale-up and IVIVC Study

By  

Current Drug Delivery, Vol. 10, Iss. 5, 2013-10 ,pp. : 548-556

Bentham Science Publishers

Access to resources Recommend Favorite

The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets

By Sirisuth N.   Eddington N.D.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 53, Iss. 3, 2002-05 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite